首页> 外文期刊>International Orthopaedics >Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy.
【24h】

Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy.

机译:使用刮除术,去毛刺和植骨术无需辅助治疗即可局部控制长骨巨细胞瘤。

获取原文
获取原文并翻译 | 示例
       

摘要

Giant cell tumour (GCT) is a benign, but aggressive, primary tumour of the bone. The recurrence rate after surgical treatment has been reported to be as high as 50%. Many surgical techniques have been employed in the treatment of this tumour. More aggressive interventions, such as en bloc resection and bulk allograft or prosthetic reconstruction, are generally understood to be associated with lower rates of local recurrence. However, because of lessened morbidity, intralesional techniques have come to be favoured for this condition. In addition to curettage, various adjuvant procedures and packing materials have been advocated in order to control and reconstruct long bone defects secondary to this neoplasm. We report our experience with 40 long bone GCT patients treated with curettage, burring, bone grafting and no adjuvants between 1997 and 2002. There was a local recurrence rate of 32.5%, with most recurrences noted within the first 30 months after surgery. Minor complications were found in 18% of patients. The risk of local recurrence in this study is acceptable (within the range that has been historically reported for curettage and bone grafting). In cases where more resources are available, the addition of adjuvant therapies, as noted in the recent literature, may be beneficial. The results of this study should be considered when designing multicenteric studies in the future.
机译:巨细胞瘤(GCT)是一种良性但侵袭性的骨原发性肿瘤。据报道,手术治疗后的复发率高达50%。在这种肿瘤的治疗中已经采用了许多外科技术。一般认为,更具攻击性的干预措施(例如整块切除和同种异体大体移植或假体重建)与较低的局部复发率相关。然而,由于发病率降低,病灶内技术已成为该病的首选。除刮除术外,已提倡各种辅助方法和包装材料,以控制和重建继发于该肿瘤的长骨缺损。我们报告了1997年至2002年间接受刮除,去毛刺,植骨和无佐剂治疗的40例长骨GCT患者的经验。局部复发率为32.5%,其中大多数复发在手术后的前30个月内出现。 18%的患者发现轻微并发症。这项研究中局部复发的风险是可以接受的(在历史上刮除和植骨的报道范围内)。在可获得更多资源的情况下,如最近文献所述,增加辅助治疗可能是有益的。将来在设计多中心研究时应考虑该研究的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号